5-amino-1mq and cd38 inhibitor synergy nad+ Heavy-chain antibody targeting of hydrolase ectoenzyme to prevent fibrosis in multiple organs A Potent and Specific CD38
A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Dysregulation of Niacin Derived NAD+ Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





